Diabetes is an important cause of morbidity and mortality in Africa. Among adults, the prevalence is expected to grow to 33 million by 2030 and 55 million by 2045. This rise has largely been ascribed to changing demography, including lifestyle and urbanization. It is not surprising that healthcare delivery for people with diabetes in this region is inadequate due to limited resources. This leads to higher disability and mortality rates, primarily due to the complications of diabetes. At present, there is a paucity of epidemiological data on diabetes in Africa.
A concerted multisectoral effort will be critical to tackle the devastating impacts, improve health outcomes, and address other key issues associated with diabetes in this region. There are also many unanswered questions related to epidemiology in the African region to engage the interest of researchers globally. The objective of this research topic is to explore the latest epidemiology of diabetes in Africa, focusing on screening, prevention, diagnosis, management, and rehabilitation. All article types accepted by Frontiers within this area of research are encouraged for submission.
Specific themes of interest include, but are not limited to:
- Major risk factors for diabetes in context to Africa (including genetic and immunological factors)
- Screening and prevention of diabetes in Africa
- Continuum of care, including the diagnosis and management of diabetes in Africa
- Treatment outcomes, including the disability and mortality patterns of diabetes in Africa
- Long-term effects and complications of diabetes in Africa, including microvascular and macrovascular complications
- The impact of comorbid diseases on projected estimates for diabetes prevalence in Africa
- Efforts to prevent, care delivery methods and healthcare challenges of diabetes in Africa
- Resource allocation relating to diabetes in Africa
- Cost-effectiveness studies strategies for prevention, diagnosis, and treatment of diabetes in Africa.
Diabetes is an important cause of morbidity and mortality in Africa. Among adults, the prevalence is expected to grow to 33 million by 2030 and 55 million by 2045. This rise has largely been ascribed to changing demography, including lifestyle and urbanization. It is not surprising that healthcare delivery for people with diabetes in this region is inadequate due to limited resources. This leads to higher disability and mortality rates, primarily due to the complications of diabetes. At present, there is a paucity of epidemiological data on diabetes in Africa.
A concerted multisectoral effort will be critical to tackle the devastating impacts, improve health outcomes, and address other key issues associated with diabetes in this region. There are also many unanswered questions related to epidemiology in the African region to engage the interest of researchers globally. The objective of this research topic is to explore the latest epidemiology of diabetes in Africa, focusing on screening, prevention, diagnosis, management, and rehabilitation. All article types accepted by Frontiers within this area of research are encouraged for submission.
Specific themes of interest include, but are not limited to:
- Major risk factors for diabetes in context to Africa (including genetic and immunological factors)
- Screening and prevention of diabetes in Africa
- Continuum of care, including the diagnosis and management of diabetes in Africa
- Treatment outcomes, including the disability and mortality patterns of diabetes in Africa
- Long-term effects and complications of diabetes in Africa, including microvascular and macrovascular complications
- The impact of comorbid diseases on projected estimates for diabetes prevalence in Africa
- Efforts to prevent, care delivery methods and healthcare challenges of diabetes in Africa
- Resource allocation relating to diabetes in Africa
- Cost-effectiveness studies strategies for prevention, diagnosis, and treatment of diabetes in Africa.